Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_assertion type Assertion NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_head.
- NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_assertion description "[The activated (phosphorylated) Stat3 is overexpressed in most paclitaxel-resistant ovarian cancer cells/interruption of Stat3 signaling could reverse resistance to paclitaxel and perhaps other chemotherapy agents in human cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_provenance.
- NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_assertion evidence source_evidence_literature NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_provenance.
- NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_assertion SIO_000772 16951221 NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_provenance.
- NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_assertion wasDerivedFrom lhgdn-20090331 NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_provenance.
- NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_assertion wasGeneratedBy ECO_0000203 NP219422.RA2yRU2GCLwEJTS1eoMM07JPx_zX_ShA8uyOSCQ1ASz1M130_provenance.